Limited therapeutic benefits of intra-articular cortisone injection for patients with femoro-acetabular impingement and labral tear

Aaron J. Krych, Timothy B. Griffith, Joshua Hudgens, Scott A. Kuzma, Rafael J. Sierra, Bruce A. Levy

Research output: Contribution to journalArticle

Abstract

Purpose: Intra-articular (IA) hip cortisone injection is commonly performed as a therapeutic modality in patients with femoral acetabular impingement (FAI). To our knowledge, there is no published data evaluating the clinical benefit of these injections. The purpose of this study was to assess the efficacy of therapeutic IA cortisone injection in these patients. Methods: At our institution, patients with FAI and labral tear prospectively recorded their numerical rating scale (NRS) pain scores pre-injection, during post-injection anaesthetic phase, and at 14 days post-injection. From this cohort, all patients treated with guided IA cortisone injection, no radiographic evidence of arthritis (Tönnis grade 0 or 1) and pain relief during the anaesthetic phase of the IA injection were included. An absolute change of two points on the NRS score was considered the minimal amount of clinically significant pain relief. Pain scores were compared between the different types of steroid injected. Results: Fifty-four patients (35 females, 19 males) with a mean age of 32 ± 12 years were included. Average median pre-injection NRS score was 7.0 (range 2.5-10.0), post-injection anaesthetic phase was 1.0 (range 0.0-5.0), and 14 day post-injection was 5.0 (range 0.0-10.0). As a group, NRS scores significantly diminished from post-injection anaesthetic phase to 14 days post-injection (p < 0.001). At 14 days post-injection, only 20 patients (37 %) and at 6 weeks, only 3 patients (6 %) reported a clinically significant decrease in pain. Average duration of pain relief was 9.8 days. There was no difference in pain reduction between steroid preparations. Conclusion: In patients with symptomatic FAI and labral tear, intra-articular cortisone injection has limited clinical benefit as a therapeutic modality. However, anaesthetic-only IA injections for patients who may be candidates for hip arthroscopy can be a useful diagnostic tool. Level of evidence: Therapeutic case series, Level IV.

Original languageEnglish (US)
Pages (from-to)750-755
Number of pages6
JournalKnee Surgery, Sports Traumatology, Arthroscopy
Volume22
Issue number4
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Femoracetabular Impingement
Intra-Articular Injections
Cortisone
Tears
Injections
Pain
Anesthetics
Thigh
Therapeutics
Hip
Steroids
Arthroscopy
Arthritis

Keywords

  • Cortisone injection
  • Diagnostic
  • FAI
  • Labral tear
  • Therapeutic injection

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Cite this

Limited therapeutic benefits of intra-articular cortisone injection for patients with femoro-acetabular impingement and labral tear. / Krych, Aaron J.; Griffith, Timothy B.; Hudgens, Joshua; Kuzma, Scott A.; Sierra, Rafael J.; Levy, Bruce A.

In: Knee Surgery, Sports Traumatology, Arthroscopy, Vol. 22, No. 4, 01.01.2014, p. 750-755.

Research output: Contribution to journalArticle

Krych, Aaron J. ; Griffith, Timothy B. ; Hudgens, Joshua ; Kuzma, Scott A. ; Sierra, Rafael J. ; Levy, Bruce A. / Limited therapeutic benefits of intra-articular cortisone injection for patients with femoro-acetabular impingement and labral tear. In: Knee Surgery, Sports Traumatology, Arthroscopy. 2014 ; Vol. 22, No. 4. pp. 750-755.
@article{d95a7496529e42f181cc4bb7ca857f28,
title = "Limited therapeutic benefits of intra-articular cortisone injection for patients with femoro-acetabular impingement and labral tear",
abstract = "Purpose: Intra-articular (IA) hip cortisone injection is commonly performed as a therapeutic modality in patients with femoral acetabular impingement (FAI). To our knowledge, there is no published data evaluating the clinical benefit of these injections. The purpose of this study was to assess the efficacy of therapeutic IA cortisone injection in these patients. Methods: At our institution, patients with FAI and labral tear prospectively recorded their numerical rating scale (NRS) pain scores pre-injection, during post-injection anaesthetic phase, and at 14 days post-injection. From this cohort, all patients treated with guided IA cortisone injection, no radiographic evidence of arthritis (T{\"o}nnis grade 0 or 1) and pain relief during the anaesthetic phase of the IA injection were included. An absolute change of two points on the NRS score was considered the minimal amount of clinically significant pain relief. Pain scores were compared between the different types of steroid injected. Results: Fifty-four patients (35 females, 19 males) with a mean age of 32 ± 12 years were included. Average median pre-injection NRS score was 7.0 (range 2.5-10.0), post-injection anaesthetic phase was 1.0 (range 0.0-5.0), and 14 day post-injection was 5.0 (range 0.0-10.0). As a group, NRS scores significantly diminished from post-injection anaesthetic phase to 14 days post-injection (p < 0.001). At 14 days post-injection, only 20 patients (37 {\%}) and at 6 weeks, only 3 patients (6 {\%}) reported a clinically significant decrease in pain. Average duration of pain relief was 9.8 days. There was no difference in pain reduction between steroid preparations. Conclusion: In patients with symptomatic FAI and labral tear, intra-articular cortisone injection has limited clinical benefit as a therapeutic modality. However, anaesthetic-only IA injections for patients who may be candidates for hip arthroscopy can be a useful diagnostic tool. Level of evidence: Therapeutic case series, Level IV.",
keywords = "Cortisone injection, Diagnostic, FAI, Labral tear, Therapeutic injection",
author = "Krych, {Aaron J.} and Griffith, {Timothy B.} and Joshua Hudgens and Kuzma, {Scott A.} and Sierra, {Rafael J.} and Levy, {Bruce A.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/s00167-014-2862-3",
language = "English (US)",
volume = "22",
pages = "750--755",
journal = "Knee Surgery, Sports Traumatology, Arthroscopy",
issn = "0942-2056",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Limited therapeutic benefits of intra-articular cortisone injection for patients with femoro-acetabular impingement and labral tear

AU - Krych, Aaron J.

AU - Griffith, Timothy B.

AU - Hudgens, Joshua

AU - Kuzma, Scott A.

AU - Sierra, Rafael J.

AU - Levy, Bruce A.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Purpose: Intra-articular (IA) hip cortisone injection is commonly performed as a therapeutic modality in patients with femoral acetabular impingement (FAI). To our knowledge, there is no published data evaluating the clinical benefit of these injections. The purpose of this study was to assess the efficacy of therapeutic IA cortisone injection in these patients. Methods: At our institution, patients with FAI and labral tear prospectively recorded their numerical rating scale (NRS) pain scores pre-injection, during post-injection anaesthetic phase, and at 14 days post-injection. From this cohort, all patients treated with guided IA cortisone injection, no radiographic evidence of arthritis (Tönnis grade 0 or 1) and pain relief during the anaesthetic phase of the IA injection were included. An absolute change of two points on the NRS score was considered the minimal amount of clinically significant pain relief. Pain scores were compared between the different types of steroid injected. Results: Fifty-four patients (35 females, 19 males) with a mean age of 32 ± 12 years were included. Average median pre-injection NRS score was 7.0 (range 2.5-10.0), post-injection anaesthetic phase was 1.0 (range 0.0-5.0), and 14 day post-injection was 5.0 (range 0.0-10.0). As a group, NRS scores significantly diminished from post-injection anaesthetic phase to 14 days post-injection (p < 0.001). At 14 days post-injection, only 20 patients (37 %) and at 6 weeks, only 3 patients (6 %) reported a clinically significant decrease in pain. Average duration of pain relief was 9.8 days. There was no difference in pain reduction between steroid preparations. Conclusion: In patients with symptomatic FAI and labral tear, intra-articular cortisone injection has limited clinical benefit as a therapeutic modality. However, anaesthetic-only IA injections for patients who may be candidates for hip arthroscopy can be a useful diagnostic tool. Level of evidence: Therapeutic case series, Level IV.

AB - Purpose: Intra-articular (IA) hip cortisone injection is commonly performed as a therapeutic modality in patients with femoral acetabular impingement (FAI). To our knowledge, there is no published data evaluating the clinical benefit of these injections. The purpose of this study was to assess the efficacy of therapeutic IA cortisone injection in these patients. Methods: At our institution, patients with FAI and labral tear prospectively recorded their numerical rating scale (NRS) pain scores pre-injection, during post-injection anaesthetic phase, and at 14 days post-injection. From this cohort, all patients treated with guided IA cortisone injection, no radiographic evidence of arthritis (Tönnis grade 0 or 1) and pain relief during the anaesthetic phase of the IA injection were included. An absolute change of two points on the NRS score was considered the minimal amount of clinically significant pain relief. Pain scores were compared between the different types of steroid injected. Results: Fifty-four patients (35 females, 19 males) with a mean age of 32 ± 12 years were included. Average median pre-injection NRS score was 7.0 (range 2.5-10.0), post-injection anaesthetic phase was 1.0 (range 0.0-5.0), and 14 day post-injection was 5.0 (range 0.0-10.0). As a group, NRS scores significantly diminished from post-injection anaesthetic phase to 14 days post-injection (p < 0.001). At 14 days post-injection, only 20 patients (37 %) and at 6 weeks, only 3 patients (6 %) reported a clinically significant decrease in pain. Average duration of pain relief was 9.8 days. There was no difference in pain reduction between steroid preparations. Conclusion: In patients with symptomatic FAI and labral tear, intra-articular cortisone injection has limited clinical benefit as a therapeutic modality. However, anaesthetic-only IA injections for patients who may be candidates for hip arthroscopy can be a useful diagnostic tool. Level of evidence: Therapeutic case series, Level IV.

KW - Cortisone injection

KW - Diagnostic

KW - FAI

KW - Labral tear

KW - Therapeutic injection

UR - http://www.scopus.com/inward/record.url?scp=84896491103&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896491103&partnerID=8YFLogxK

U2 - 10.1007/s00167-014-2862-3

DO - 10.1007/s00167-014-2862-3

M3 - Article

C2 - 24488223

AN - SCOPUS:84896491103

VL - 22

SP - 750

EP - 755

JO - Knee Surgery, Sports Traumatology, Arthroscopy

JF - Knee Surgery, Sports Traumatology, Arthroscopy

SN - 0942-2056

IS - 4

ER -